遊客:
註冊
|
登錄
|
會員
巴菲特班 洪瑞泰 (Michael On)
»
討論區1
» 日股..製藥..Shionogi 塩野義製薬(日股 4507,美股 SGIOY,SGIOF)
投票
交易
懸賞
活動
打印
|
推薦
|
訂閱
|
收藏
標題: 日股..製藥..Shionogi 塩野義製薬(日股 4507,美股 SGIOY,SGIOF)
kaka
同學
UID 6717
精華 0
積分 0
帖子 6266
閱讀權限 99
註冊 2014-5-7
用戶註冊天數 3613
用戶失蹤天數 1720
111.83.18.104
#1
分享
發表於 2017-11-5 17:07
資料
私人訊息
日股..製藥..Shionogi 塩野義製薬(日股 4507,美股 SGIOY,SGIOF)
日股..製藥..Shionogi 塩野義製薬株式会社(日股 4507,美股 SGIOY,SGIOF)
日經225指數成分股
http://www.investor.com.tw/nfastnews/ADgif/AD_content/060227_09/0227_09n225-01.htm
http://www.shionogi.co.jp
https://en.wikipedia.org/wiki/Shionogi
Shionogi & Company, Limited (塩野義製薬株式会社,
Shionogi Seiyaku Kabushiki Kaisha
) is a
Japanese
pharmaceutical company
best known for developing
Crestor
. Medical supply and brand name also uses Shionogi ("Ёレвヰ").
Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for
hyperlipidaemia
,
antibiotics
, and
cancer
medicines.
In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based
Schering-Plough
to become a sole marketing agent for its products in Japan.
Shionogi had supported the initial formation of
Ranbaxy Pharmaceuticals
, a generic manufacturer based in
India
. In 2012 the company became a partial owner of
ViiV Healthcare
, a pharmaceutical company specialising in the development of therapies for
HIV
.
[3]
The company is listed on the
Tokyo Stock Exchange
and
Osaka Securities Exchange
and is constituent of the
Nikkei 225
stock index.
[4]
投票
交易
懸賞
活動
Powered by
Discuz!
© Comsenz Inc.
檢舉論壇